⌘K
Loading ticker…
As of 2026-09-10, DataMeds AI, Inc. Common Stock (MEDS) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 15.8 (Defensive). Sector: Consumer Staples, ranked 7 of 11. Average daily range 12.5%, relative volume 0.12×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
MEDS is held by 2 ETFs as of Jun 2026. Top owner: VXF at 0.00% weight, $28K notional.
Held by 2 ETFs · $34K across latest filings · largest weight 0.00% (VXF).
Top 2 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $28K | new |
| VTIVanguard Total Stock Market ETF | 0.00% | $6K | new |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MEDS Jan avg: -7.69% median: -7.69% win: 50% σ: 17.06% n: 2 2022-04-12 → 2026-08-31 | MEDS Feb avg: 63.72% median: 63.72% win: 50% σ: 91.33% n: 2 2022-04-12 → 2026-08-31 | MEDS Mar avg: -10.81% median: -10.81% win: 50% σ: 25.99% n: 2 2022-04-12 → 2026-08-31 | MEDS Apr avg: -14.51% median: -15.00% win: 33% σ: 27.54% n: 3 2022-04-12 → 2026-08-31 | MEDS May avg: -4.96% median: -8.92% win: 33% σ: 13.66% n: 3 2022-04-12 → 2026-08-31 | MEDS Jun avg: 95.12% median: 70.02% win: 100% σ: 105.31% n: 3 2022-04-12 → 2026-08-31 | MEDS Jul avg: -28.56% median: -28.24% win: 25% σ: 28.34% n: 4 2022-04-12 → 2026-08-31 | MEDS Aug avg: -28.41% median: -24.25% win: 25% σ: 29.80% n: 4 2022-04-12 → 2026-08-31 | MEDS Sep avg: -4.83% median: -3.92% win: 0% σ: 2.81% n: 3 2022-04-12 → 2026-08-31 (current) | MEDS Oct avg: -19.23% median: -19.23% win: 0% σ: 2.85% n: 2 2022-04-12 → 2026-08-31 | MEDS Nov avg: -18.00% median: -18.00% win: 50% σ: 26.19% n: 2 2022-04-12 → 2026-08-31 | MEDS Dec avg: -19.96% median: -19.96% win: 0% σ: 12.42% n: 2 2022-04-12 → 2026-08-31 |